Natural Alternatives International (NASDAQ:NAII) Coverage Initiated at StockNews.com

Posted by Caroline Horne on Dec 22nd, 2024

Equities research analysts at StockNews.com assumed coverage on shares of Natural Alternatives International (NASDAQ:NAII – Get Free Report) in a research report issued to clients and investors on Friday. The firm set a “buy” rating on the stock.

Natural Alternatives International Trading Up 2.4 %

Shares of NASDAQ:NAII opened at $4.24 on Friday. The firm has a market cap of $26.28 million, a P/E ratio of -2.94 and a beta of 0.60. The company has a current ratio of 2.56, a quick ratio of 1.50 and a debt-to-equity ratio of 0.11. Natural Alternatives International has a twelve month low of $4.02 and a twelve month high of $7.26. The company has a 50 day moving average of $4.43 and a 200-day moving average of $5.35.

Natural Alternatives International (NASDAQ:NAII – Get Free Report) last released its earnings results on Friday, September 27th. The company reported ($0.32) earnings per share (EPS) for the quarter. Natural Alternatives International had a negative return on equity of 10.23% and a negative net margin of 7.53%. The firm had revenue of $29.49 million for the quarter.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Natural Alternatives International stock. Geode Capital Management LLC grew its stake in shares of Natural Alternatives International, Inc. (NASDAQ:NAII – Free Report) by 6.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 45,062 shares of the company’s stock after purchasing an additional 2,915 shares during the period. Geode Capital Management LLC owned about 0.73% of Natural Alternatives International worth $258,000 as of its most recent SEC filing. Institutional investors and hedge funds own 32.40% of the company’s stock.

About Natural Alternatives International

(Get Free Report)

Natural Alternatives International, Inc engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.